Sangamo Therapeutics (SGMOQ) Non-Current Deffered Revenue (2012 - 2025)
Sangamo Therapeutics' Non-Current Deffered Revenue was $5.87 million in Q4 2025, unchanged from $5.87 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Non-Current Deffered Revenue (2012 - 2025) Analysis & Trends
From Q1 2012 onward, Sangamo Therapeutics has reported Non-Current Deffered Revenue for 50 quarters.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of -52.6% (FY2020 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $5.87 million in FY2024, $109.38 million in FY2022 (-34.4%) and $166.78 million in FY2021 (-31.9%).
- Quarterly Non-Current Deffered Revenue has moved between $1.82 million (Q1 2023) and $222.28 million (Q1 2021) over five years.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q1 2021 (growth of 195.3%); the worst was Q1 2023 (a decline of 98.8%).
- Per Business Quant data, SGMOQ's Non-Current Deffered Revenue in the three quarters before Q4 2025 was $5.87 million (Q3 2025), $5.87 million (Q2 2025) and $5.87 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Sangamo Therapeutics | 42.03 Mn | -72.08 Mn | - | 5.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 5.87 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 5.87 Mn |
| Dec 31, 2024 | 5.87 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 109.38 Mn |
| Sep 30, 2022 | 115.64 Mn |
| Jun 30, 2022 | 129.92 Mn |
| Mar 31, 2022 | 150.70 Mn |
| Dec 31, 2021 | 166.78 Mn |
| Sep 30, 2021 | 183.94 Mn |
| Jun 30, 2021 | 201.25 Mn |
| Mar 31, 2021 | 222.28 Mn |
| Dec 31, 2020 | 245.05 Mn |
| Sep 30, 2020 | 267.90 Mn |
| Jun 30, 2020 | 237.64 Mn |
| Mar 31, 2020 | 75.27 Mn |
| Dec 31, 2019 | 81.43 Mn |
| Sep 30, 2019 | 87.80 Mn |
API Access
Sangamo Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();